Shots: The US FDA has approved Keytruda’s additional recommended dosage of 400 mg (q6w) across all adult indications, including monothx. and combination therapy. The new dosage option will be available in addition to the current dose of Keytruda (200 mg, q3w) The indication is approved under accelerated approval based on PK data, the relationship of […]Read More
Tags : Recommended Dose
Latest Posts
Categories
Related Topics
AbbVie
Acquire
Adults
Agreement
Amgen
approval
AstraZeneca
Bayer
Biosimilar
BMS
Collaborate
Collaborates
Collaboration
Commercialize
COVID-19
Develop
Development
Eli Lilly
Exclusive
FDA
Gilead
GSK
Janssen
Launches
License
License Agreement
Merck
Novartis
P-III
patients
Pfizer
receives
Regeneron
Report
reports
results
Roche
Sanofi
Signs
study
Takeda
the US FDA
Treat
Treatment
US